Alum designs FDA-authorized app to treat fibromyalgia symptoms
Learning to design furniture at San Francisco State University can lead to more careers than one may expect. For Nelson Mitchell, his master’s degree was the pathway to creating an innovative mobile app to treat fibromyalgia.
Mitchell, a user-experience designer, is head of design and co-founder of Swing Therapeutics. Earlier this year the Federal Drug Administration (FDA) authorized its app, Stanza, to be marketed to treat symptoms of fibromyalgia, a chronic pain condition that affects 10 million Americans. It is the first fibromyalgia digital therapeutic approved by the FDA. Available only by prescription, Stanza employs a form of cognitive behavioral therapy called acceptance and commitment therapy. It has proven effective in extensive randomized controlled trials and real-world studies, with 73% of patients demonstrating improvement in symptoms.